Prana P1 THC

**Prana P1 THC** is a cannabinoid-based medicinal product developed by United Cannabis Corporation, featuring delta-9-tetrahydrocannabinol (THC) and potentially tetrahydrocannabinolic acid (THCA) in capsule form for oral administration. It is designed for micro-dosing with THC dosages ranging from 1mg to 50mg, aimed at symptom management in conditions such as chronic pain, anxiety, PTSD, and others through modulation of the endocannabinoid system via CB1 and CB2 receptors. Clinical trials, including pharmacokinetic studies with single oral doses of 10mg or 20mg, have been initiated to evaluate its safety and efficacy, positioning it as a first-in-class cannabis-derived therapy with patent protection.[1][3][10][11]

Brand names

Prana P1 THCPrana P1

Other names

Prana Bio Nutrient Medicinals P1 Capsules